T-cell therapy for sarcoma

The FDA has granted accelerated approval to afamitresgene autoleucel for the treatment of unresectable or metastatic synovial sarcoma

August 2024: The Food and Drug Administration has given accelerated approval to afamitresgene autoleucel (TECELRA, Adaptimmune, LLC), a genetically modified autologous T cell immunotherapy that target...
t-cell-therapy-for-sarcoma

Scan the code

Tag: T-cell therapy for sarcoma

Home / T-cell therapy for sarcoma

Categories

The FDA has granted accelerated approval to afamitresgene autoleucel for the treatment of unresectable or metastatic synovial sarcoma

Information

Treatment

United States

Romania

India (Hyderabad)

Cambodia

China (Shanghai)

China (Beijing)

Hong Kong